Literature DB >> 19118017

Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.

Christophe Cataisson1, Rebecca Ohman, Gopal Patel, Andrea Pearson, Margaret Tsien, Steve Jay, Lisa Wright, Henry Hennings, Stuart H Yuspa.   

Abstract

Transgenic mice that overexpress PKCalpha in the epidermis (K5-PKCalpha mice) exhibit acute CXCR2-mediated intraepidermal neutrophilic inflammation and a strong epidermal hyperplasia in response to application of 12-O-tetradecanoylphorbol-13-acetate (TPA). We now show that hyperplasia is independent of infiltrating neutrophils. Furthermore, when K5-PKCalpha mice were initiated with 7,12-dimethylbenz(a)anthracene (DMBA) and promoted with a low dose of TPA, 58% of K5-PKCalpha mice developed skin papillomas that progressed to carcinoma, whereas wild-type mice did not develop tumors. We confirmed that CXCR2 is expressed by keratinocytes and showed that transformation by oncogenic ras (a hallmark of DMBA initiation) or TPA exposure induced all CXCR2 ligands. Ras induction of CXCR2 ligands was mediated by autocrine activation of epidermal growth factor receptor and nuclear factor-kappaB, and potentiated by PKCalpha. Oncogenic ras also induced CXCR2 ligands in keratinocytes genetically ablated for CXCR2. However, ras transformed CXCR2 null keratinocytes formed only small skin tumors in orthotopic skin grafts to CXCR2 intact hosts, whereas transformed wild-type keratinocytes produced large tumors. In vitro, CXCR2 was essential for CXCR2 ligand-stimulated migration of ras-transformed keratinocytes and for ligand activation of the extracellular signal-regulated kinase (ERK) and Akt pathways. Both migration and activation of ERK and Akt were restored by CXCR2 reconstitution of CXCR2 null keratinocytes. Thus, activation of CXCR2 on ras-transformed keratinocytes has both promigratory and protumorigenic functions. The up-regulation of CXCR2 ligands after initiation by oncogenic ras and promotion with TPA in the mouse skin model provides a mechanism to stimulate migration by both autocrine and paracrine pathways and contribute to tumor development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19118017      PMCID: PMC2872171          DOI: 10.1158/0008-5472.CAN-08-2490

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Evidence that initiated keratinocytes clonally expand into multiple existing hair follicles during papilloma histogenesis in SENCAR mouse skin.

Authors:  R L Binder; P M Gallagher; G R Johnson; S L Stockman; B J Smith; J P Sundberg; C J Conti
Journal:  Mol Carcinog       Date:  1997-09       Impact factor: 4.784

2.  Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.

Authors:  J R White; J M Lee; P R Young; R P Hertzberg; A J Jurewicz; M A Chaikin; K Widdowson; J J Foley; L D Martin; D E Griswold; H M Sarau
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

3.  Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

Authors:  R J Moore; D M Owens; G Stamp; C Arnott; F Burke; N East; H Holdsworth; L Turner; B Rollins; M Pasparakis; G Kollias; F Balkwill
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

4.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.

Authors:  L M Coussens; W W Raymond; G Bergers; M Laig-Webster; O Behrendtsen; Z Werb; G H Caughey; D Hanahan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

5.  Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431.

Authors:  B Metzner; C Hofmann; C Heinemann; U Zimpfer; I Schraufstätter; E Schöpf; J Norgauer
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

6.  Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.

Authors:  A A Dlugosz; L Hansen; C Cheng; N Alexander; M F Denning; D W Threadgill; T Magnuson; R J Coffey; S H Yuspa
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

7.  Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.

Authors:  A A Dlugosz; C Cheng; E K Williams; N Darwiche; P J Dempsey; B Mann; A R Dunn; R J Coffey; S H Yuspa
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

Review 8.  The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis.

Authors:  S H Yuspa
Journal:  J Dermatol Sci       Date:  1998-05       Impact factor: 4.563

9.  Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways.

Authors:  Christophe Cataisson; Elizabeth Joseloff; Rodolfo Murillas; Alice Wang; Coralyn Atwell; Sara Torgerson; Michael Gerdes; Jeffrey Subleski; Ji-Liang Gao; Philip M Murphy; Robert H Wiltrout; Charles Vinson; Stuart H Yuspa
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

10.  Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion.

Authors:  H Q Wang; R C Smart
Journal:  J Cell Sci       Date:  1999-10       Impact factor: 5.285

View more
  35 in total

1.  CXCR2 and its related ligands play a novel role in supporting the pluripotency and proliferation of human pluripotent stem cells.

Authors:  Ji-Hye Jung; Seung Jin Lee; JiHea Kim; SongHee Lee; Hwa-Jung Sung; Jungsuk An; Yong Park; Byung Soo Kim
Journal:  Stem Cells Dev       Date:  2014-12-23       Impact factor: 3.272

2.  Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer.

Authors:  Lisa Nolan Wright; Andrew Ryscavage; Glenn Merlino; Stuart H Yuspa
Journal:  Clin Cancer Res       Date:  2011-11-08       Impact factor: 12.531

3.  CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.

Authors:  Ashley E Winkler; Joshua J Brotman; Meredith E Pittman; Nancy P Judd; James S Lewis; Robert D Schreiber; Ravindra Uppaluri
Journal:  Cancer Res       Date:  2011-07-06       Impact factor: 12.701

4.  Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase Cε with Stat3 involve integration with ERK1/2.

Authors:  Jordan Marshall Sand; Bilal Bin Hafeez; Moammir Hasan Aziz; Emily Marie Siebers; Nancy Ellen Dreckschmidt; Ajit Kumar Verma
Journal:  Mol Carcinog       Date:  2011-04-07       Impact factor: 4.784

Review 5.  Modeling cutaneous squamous carcinoma development in the mouse.

Authors:  Phillips Y Huang; Allan Balmain
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

6.  Effect of suppressive oligodeoxynucleotides on the development of inflammation-induced papillomas.

Authors:  Hidekazu Ikeuchi; Takeshi Kinjo; Dennis M Klinman
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-02

Review 7.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

8.  Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin.

Authors:  Daryle Depianto; Michelle L Kerns; Andrzej A Dlugosz; Pierre A Coulombe
Journal:  Nat Genet       Date:  2010-09-26       Impact factor: 38.330

9.  Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications.

Authors:  Wen G Jiang; Andrew J Sanders; Fiona Ruge; Keith G Harding
Journal:  Exp Ther Med       Date:  2011-12-01       Impact factor: 2.447

10.  CXCL3 Signaling in the Tumor Microenvironment.

Authors:  Niradiz Reyes; Stephanie Figueroa; Raj Tiwari; Jan Geliebter
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.